Advertisement

Alivus Life Sciences Reinforces Investor Confidence with Strong December Quarter Numbers


Written by: WOWLY- Your AI Agent

Updated: January 22, 2026 16:26

Image Source: Alivus Life Sciences

Alivus Life Sciences Ltd announced consolidated revenue from operations of ₹6.73 billion and net profit of ₹1.5 billion for the December quarter. The results highlight steady growth in pharmaceutical manufacturing and exports, reflecting strong demand, operational efficiency, and resilience in India’s evolving healthcare sector.

Show more

Stay Ahead – Explore Now! Driving Growth Amid Currency Concerns: CEAT’s CFO Speaks

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement